APO Research
Talk to an analyst

APO RESEARCH · REPORT

VLP Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global VLP Vaccines Industry Growth and Trends Forecast to 2032

2 January 2026108 pages

Choose your research edition.

Industry ResearchVLP Vaccines Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal VLP Vaccines Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal VLP Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal VLP Vaccines Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal VLP Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global VLP Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for VLP Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for VLP Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for VLP Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of VLP Vaccines include H&Z Life Science, Merck, Gproan, VLP Therapeutics, VBI, Spybiotech, Saiba Animal Health, POSVAX and Optipharm Co. Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global VLP Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The VLP Vaccines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global VLP Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to VLP Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global VLP Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

VLP Vaccines Market by Company

H&Z Life Science

Merck

Gproan

VLP Therapeutics

VBI

Spybiotech

Saiba Animal Health

POSVAX

Optipharm Co. Ltd

Novavax

Medicago

ARTES Biotechnology

VLP Vaccines Segment by Type

Hepatitis B Vaccine

Covid-19 Vaccine

HPV Vaccine

Others

VLP Vaccines Segment by Application

Government

Medical Institution

Others

VLP Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global VLP Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of VLP Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of VLP Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of VLP Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of VLP Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hepatitis B Vaccine Table 2. Major Company of Covid-19 Vaccine Table 3. Major Company of HPV Vaccine Table 4. Major Company of Others Table 5. Global VLP Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global VLP Vaccines Sales by Type (2021-2026) & (K Units) Table 7. Global VLP Vaccines Sales Market Share in Volume by Type (2021-2026) Table 8. Global VLP Vaccines Sales by Type (2021-2026) & (US$ Million) Table 9. Global VLP Vaccines Sales Market Share in Value by Type (2021-2026) Table 10. Global VLP Vaccines Price by Type (2021-2026) & (US$/Unit) Table 11. Global VLP Vaccines Sales by Type (2027-2032) & (K Units) Table 12. Global VLP Vaccines Sales Market Share in Volume by Type (2027-2032) Table 13. Global VLP Vaccines Sales by Type (2027-2032) & (US$ Million) Table 14. Global VLP Vaccines Sales Market Share in Value by Type (2027-2032) Table 15. Global VLP Vaccines Price by Type (2027-2032) & (US$/Unit) Table 16. North America VLP Vaccines Sales by Type (2021-2026) & (K Units) Table 17. North America VLP Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Europe VLP Vaccines Sales by Type (2021-2026) & (K Units) Table 19. Europe VLP Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific VLP Vaccines Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific VLP Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America VLP Vaccines Sales by Type (2021-2026) & (K Units) Table 23. Latin America VLP Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa VLP Vaccines Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa VLP Vaccines Sales by Type (2021-2026) & (US$ Million) Table 26. VLP Vaccines Industry Trends Table 27. VLP Vaccines Industry Drivers Table 28. VLP Vaccines Industry Opportunities and Challenges Table 29. VLP Vaccines Industry Restraints Table 30. Global VLP Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global VLP Vaccines Revenue Market Share by Company (2021-2026) Table 32. Global VLP Vaccines Sales by Company (2021-2026) & (K Units) Table 33. Global VLP Vaccines Sales Share by Company (2021-2026) Table 34. Global VLP Vaccines Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global VLP Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global VLP Vaccines Major Company Production Sites and Headquarters Table 37. Global VLP Vaccines Company, Product Type & Application Table 38. Global VLP Vaccines Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global VLP Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global VLP Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global VLP Vaccines Sales by Region (2021-2026) & (K Units) Table 43. Global VLP Vaccines Sales Market Share in Volume by Region (2021-2026) Table 44. Global VLP Vaccines Sales by Region (2021-2026) & (US$ Million) Table 45. Global VLP Vaccines Sales Market Share in Value by Region (2021-2026) Table 46. Global VLP Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global VLP Vaccines Sales by Region (2027-2032) & (K Units) Table 48. Global VLP Vaccines Sales Market Share in Volume by Region (2027-2032) Table 49. Global VLP Vaccines Sales by Region (2027-2032) & (US$ Million) Table 50. Global VLP Vaccines Sales Market Share in Value by Region (2027-2032) Table 51. Global VLP Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global VLP Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global VLP Vaccines Sales by Application (2021-2026) & (K Units) Table 54. Global VLP Vaccines Sales Market Share in Volume by Application (2021-2026) Table 55. Global VLP Vaccines Sales by Application (2021-2026) & (US$ Million) Table 56. Global VLP Vaccines Sales Market Share in Value by Application (2021-2026) Table 57. Global VLP Vaccines Price by Application (2021-2026) & (US$/Unit) Table 58. Global VLP Vaccines Sales by Application (2027-2032) & (K Units) Table 59. Global VLP Vaccines Sales Market Share in Volume by Application (2027-2032) Table 60. Global VLP Vaccines Sales by Application (2027-2032) & (US$ Million) Table 61. Global VLP Vaccines Sales Market Share in Value by Application (2027-2032) Table 62. Global VLP Vaccines Price by Application (2027-2032) & (US$/Unit) Table 63. North America VLP Vaccines Sales by Application (2021-2026) & (K Units) Table 64. North America VLP Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Europe VLP Vaccines Sales by Application (2021-2026) & (K Units) Table 66. Europe VLP Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific VLP Vaccines Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific VLP Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America VLP Vaccines Sales by Application (2021-2026) & (K Units) Table 70. Latin America VLP Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa VLP Vaccines Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa VLP Vaccines Sales by Application (2021-2026) & (US$ Million) Table 73. H&Z Life Science Company Information Table 74. H&Z Life Science Business Overview Table 75. H&Z Life Science VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. H&Z Life Science VLP Vaccines Product Portfolio Table 77. H&Z Life Science Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merck VLP Vaccines Product Portfolio Table 82. Merck Recent Development Table 83. Gproan Company Information Table 84. Gproan Business Overview Table 85. Gproan VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Gproan VLP Vaccines Product Portfolio Table 87. Gproan Recent Development Table 88. VLP Therapeutics Company Information Table 89. VLP Therapeutics Business Overview Table 90. VLP Therapeutics VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. VLP Therapeutics VLP Vaccines Product Portfolio Table 92. VLP Therapeutics Recent Development Table 93. VBI Company Information Table 94. VBI Business Overview Table 95. VBI VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. VBI VLP Vaccines Product Portfolio Table 97. VBI Recent Development Table 98. Spybiotech Company Information Table 99. Spybiotech Business Overview Table 100. Spybiotech VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Spybiotech VLP Vaccines Product Portfolio Table 102. Spybiotech Recent Development Table 103. Saiba Animal Health Company Information Table 104. Saiba Animal Health Business Overview Table 105. Saiba Animal Health VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Saiba Animal Health VLP Vaccines Product Portfolio Table 107. Saiba Animal Health Recent Development Table 108. POSVAX Company Information Table 109. POSVAX Business Overview Table 110. POSVAX VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. POSVAX VLP Vaccines Product Portfolio Table 112. POSVAX Recent Development Table 113. Optipharm Co. Ltd Company Information Table 114. Optipharm Co. Ltd Business Overview Table 115. Optipharm Co. Ltd VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Optipharm Co. Ltd VLP Vaccines Product Portfolio Table 117. Optipharm Co. Ltd Recent Development Table 118. Novavax Company Information Table 119. Novavax Business Overview Table 120. Novavax VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Novavax VLP Vaccines Product Portfolio Table 122. Novavax Recent Development Table 123. Medicago Company Information Table 124. Medicago Business Overview Table 125. Medicago VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Medicago VLP Vaccines Product Portfolio Table 127. Medicago Recent Development Table 128. ARTES Biotechnology Company Information Table 129. ARTES Biotechnology Business Overview Table 130. ARTES Biotechnology VLP Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. ARTES Biotechnology VLP Vaccines Product Portfolio Table 132. ARTES Biotechnology Recent Development Table 133. North America VLP Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. North America VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 135. North America VLP Vaccines Sales Market Share by Country (2021-2026) Table 136. North America VLP Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 137. North America VLP Vaccines Sales Market Share Forecast by Country (2027-2032) Table 138. North America VLP Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America VLP Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 140. North America VLP Vaccines Market Share by Country (2021-2026) Table 141. North America VLP Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America VLP Vaccines Market Share Forecast by Country (2027-2032) Table 143. Europe VLP Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Europe VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 145. Europe VLP Vaccines Sales Market Share by Country (2021-2026) Table 146. Europe VLP Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 147. Europe VLP Vaccines Sales Market Share Forecast by Country (2027-2032) Table 148. Europe VLP Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe VLP Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe VLP Vaccines Market Share by Country (2021-2026) Table 151. Europe VLP Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe VLP Vaccines Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific VLP Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 155. Asia-Pacific VLP Vaccines Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific VLP Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 157. Asia-Pacific VLP Vaccines Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific VLP Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific VLP Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific VLP Vaccines Market Share by Country (2021-2026) Table 161. Asia-Pacific VLP Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific VLP Vaccines Market Share Forecast by Country (2027-2032) Table 163. Latin America VLP Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Latin America VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 165. Latin America VLP Vaccines Sales Market Share by Country (2021-2026) Table 166. Latin America VLP Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 167. Latin America VLP Vaccines Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America VLP Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America VLP Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America VLP Vaccines Market Share by Country (2021-2026) Table 171. Latin America VLP Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America VLP Vaccines Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa VLP Vaccines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa VLP Vaccines Sales by Country (2021-2026) & (K Units) Table 175. Middle East and Africa VLP Vaccines Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa VLP Vaccines Sales Forecast by Country (2027-2032) & (K Units) Table 177. Middle East and Africa VLP Vaccines Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa VLP Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa VLP Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa VLP Vaccines Market Share by Country (2021-2026) Table 181. Middle East and Africa VLP Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa VLP Vaccines Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. VLP Vaccines Distributors List Table 186. VLP Vaccines Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. VLP Vaccines Image Figure 2. Global VLP Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global VLP Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global VLP Vaccines Sales (2021-2032) & (K Units) Figure 5. Hepatitis B Vaccine Image Figure 6. Global Hepatitis B Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Covid-19 Vaccine Image Figure 8. Global Covid-19 Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. HPV Vaccine Image Figure 10. Global HPV Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global VLP Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global VLP Vaccines Market Share by Type 2025 VS 2032 Figure 15. North America VLP Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. North America VLP Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Europe VLP Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Europe VLP Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific VLP Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific VLP Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Latin America VLP Vaccines Sales Market Share in Volume by Type in 2025 Figure 22. Latin America VLP Vaccines Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa VLP Vaccines Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa VLP Vaccines Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 VLP Vaccines Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Government Image Figure 28. Global Government Sales YoY Growth (2021-2032) & (K Units) Figure 29. Medical Institution Image Figure 30. Global Medical Institution Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global VLP Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global VLP Vaccines Market Share by Application 2025 VS 2032 Figure 35. North America VLP Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. North America VLP Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Europe VLP Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Europe VLP Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific VLP Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific VLP Vaccines Sales Market Share in Value by Application in 2025 Figure 41. Latin America VLP Vaccines Sales Market Share in Volume by Application in 2025 Figure 42. Latin America VLP Vaccines Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa VLP Vaccines Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa VLP Vaccines Sales Market Share in Value by Application in 2025 Figure 45. North America VLP Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America VLP Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America VLP Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America VLP Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe VLP Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe VLP Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe VLP Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe VLP Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific VLP Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific VLP Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific VLP Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific VLP Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America VLP Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America VLP Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America VLP Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America VLP Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa VLP Vaccines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa VLP Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa VLP Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa VLP Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. VLP Vaccines Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. VLP Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis B Vaccine
  • Covid-19 Vaccine
  • HPV Vaccine
  • Others
Applications
  • Government
  • Medical Institution
  • Others
Companies covered
  • H&Z Life Science
  • Merck
  • Gproan
  • VLP Therapeutics
  • VBI
  • Spybiotech
  • Saiba Animal Health
  • POSVAX
  • Optipharm Co. Ltd
  • Novavax
  • Medicago
  • ARTES Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global VLP Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global VLP Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 VLP Vaccines Market by Type
  6. 1.3.1 Hepatitis B Vaccine
  7. 1.3.2 Covid-19 Vaccine
  8. 1.3.3 HPV Vaccine
  9. 1.3.4 Others
  10. 1.4 Global VLP Vaccines Market Size by Type
  11. 1.4.1 Global VLP Vaccines Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global VLP Vaccines Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global VLP Vaccines Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America VLP Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe VLP Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific VLP Vaccines Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America VLP Vaccines Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa VLP Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 VLP Vaccines Industry Trends
  2. 2.2 VLP Vaccines Industry Drivers
  3. 2.3 VLP Vaccines Industry Opportunities and Challenges
  4. 2.4 VLP Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by VLP Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by VLP Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by VLP Vaccines Price (2021-2026)
  4. 3.4 Global VLP Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global VLP Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global VLP Vaccines Company, Product Type & Application
  7. 3.7 Global VLP Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global VLP Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 VLP Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 VLP Vaccines Tier 1, Tier 2, and Tier 3
4 VLP Vaccines Regional Status and Outlook
  1. 4.1 Global VLP Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global VLP Vaccines Historic Market Size by Region
  3. 4.2.1 Global VLP Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global VLP Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global VLP Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global VLP Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global VLP Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global VLP Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global VLP Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 VLP Vaccines by Application
  1. 5.1 VLP Vaccines Market by Application
  2. 5.1.1 Government
  3. 5.1.2 Medical Institution
  4. 5.1.3 Others
  5. 5.2 Global VLP Vaccines Market Size by Application
  6. 5.2.1 Global VLP Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global VLP Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global VLP Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America VLP Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe VLP Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific VLP Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America VLP Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa VLP Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 H&Z Life Science
  2. 6.1.1 H&Z Life Science Company Information
  3. 6.1.2 H&Z Life Science Business Overview
  4. 6.1.3 H&Z Life Science VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 H&Z Life Science VLP Vaccines Product Portfolio
  6. 6.1.5 H&Z Life Science Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck VLP Vaccines Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Gproan
  14. 6.3.1 Gproan Company Information
  15. 6.3.2 Gproan Business Overview
  16. 6.3.3 Gproan VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Gproan VLP Vaccines Product Portfolio
  18. 6.3.5 Gproan Recent Developments
  19. 6.4 VLP Therapeutics
  20. 6.4.1 VLP Therapeutics Company Information
  21. 6.4.2 VLP Therapeutics Business Overview
  22. 6.4.3 VLP Therapeutics VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 VLP Therapeutics VLP Vaccines Product Portfolio
  24. 6.4.5 VLP Therapeutics Recent Developments
  25. 6.5 VBI
  26. 6.5.1 VBI Company Information
  27. 6.5.2 VBI Business Overview
  28. 6.5.3 VBI VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 VBI VLP Vaccines Product Portfolio
  30. 6.5.5 VBI Recent Developments
  31. 6.6 Spybiotech
  32. 6.6.1 Spybiotech Company Information
  33. 6.6.2 Spybiotech Business Overview
  34. 6.6.3 Spybiotech VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Spybiotech VLP Vaccines Product Portfolio
  36. 6.6.5 Spybiotech Recent Developments
  37. 6.7 Saiba Animal Health
  38. 6.7.1 Saiba Animal Health Company Information
  39. 6.7.2 Saiba Animal Health Business Overview
  40. 6.7.3 Saiba Animal Health VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Saiba Animal Health VLP Vaccines Product Portfolio
  42. 6.7.5 Saiba Animal Health Recent Developments
  43. 6.8 POSVAX
  44. 6.8.1 POSVAX Company Information
  45. 6.8.2 POSVAX Business Overview
  46. 6.8.3 POSVAX VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 POSVAX VLP Vaccines Product Portfolio
  48. 6.8.5 POSVAX Recent Developments
  49. 6.9 Optipharm Co. Ltd
  50. 6.9.1 Optipharm Co. Ltd Company Information
  51. 6.9.2 Optipharm Co. Ltd Business Overview
  52. 6.9.3 Optipharm Co. Ltd VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Optipharm Co. Ltd VLP Vaccines Product Portfolio
  54. 6.9.5 Optipharm Co. Ltd Recent Developments
  55. 6.10 Novavax
  56. 6.10.1 Novavax Company Information
  57. 6.10.2 Novavax Business Overview
  58. 6.10.3 Novavax VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novavax VLP Vaccines Product Portfolio
  60. 6.10.5 Novavax Recent Developments
  61. 6.11 Medicago
  62. 6.11.1 Medicago Company Information
  63. 6.11.2 Medicago Business Overview
  64. 6.11.3 Medicago VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Medicago VLP Vaccines Product Portfolio
  66. 6.11.5 Medicago Recent Developments
  67. 6.12 ARTES Biotechnology
  68. 6.12.1 ARTES Biotechnology Company Information
  69. 6.12.2 ARTES Biotechnology Business Overview
  70. 6.12.3 ARTES Biotechnology VLP Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 ARTES Biotechnology VLP Vaccines Product Portfolio
  72. 6.12.5 ARTES Biotechnology Recent Developments
7 North America by Country
  1. 7.1 North America VLP Vaccines Sales by Country
  2. 7.1.1 North America VLP Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America VLP Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America VLP Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America VLP Vaccines Market Size by Country
  6. 7.2.1 North America VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America VLP Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America VLP Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe VLP Vaccines Sales by Country
  2. 8.1.1 Europe VLP Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe VLP Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe VLP Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe VLP Vaccines Market Size by Country
  6. 8.2.1 Europe VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe VLP Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe VLP Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific VLP Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific VLP Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific VLP Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific VLP Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific VLP Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific VLP Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific VLP Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America VLP Vaccines Sales by Country
  2. 10.1.1 South America VLP Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America VLP Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America VLP Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America VLP Vaccines Market Size by Country
  6. 10.2.1 South America VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America VLP Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America VLP Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa VLP Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa VLP Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa VLP Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa VLP Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa VLP Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa VLP Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa VLP Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa VLP Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 VLP Vaccines Value Chain Analysis
  2. 12.1.1 VLP Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 VLP Vaccines Production Mode & Process
  7. 12.2 VLP Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 VLP Vaccines Distributors
  10. 12.2.3 VLP Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst